The therapeutic use of ototoxic drugs is relatively common, particularly in patients with severe diseases. It is likely that disturbances of balance in these patients are underestimated by clinicians.
INTRODUCTION
Labyrinthine injuries are some of the most frequent causes of vertigo and alterations of balance. An acute damage of the posterior labyrinth usually causes rotational vertigo, although sometimes, the absence of compensation may cause a persistent instability. When both labyrinths are simultaneously damaged, the predominant symptom from the beginning is instability, which may become severe and impair the ability of patients to perform their daily activities [1] .
Causes of bilateral vestibulopathy are varied and not always easy to be identified and include Menière's disease, CANVAS syndrome (cerebellar ataxia with neuropathy and vestibular areflexia syndrome), meningitis, and ototoxicity. It is well known that ototoxicity is caused by aminoglycoside antibiotics [2, 3] . However, ototoxic effects induced by other drugs, such as salicylates, some chemotherapeutic agents, other non-aminoglycoside antibiotics, or sildenafil, have also been reported. Thus far, most studies on drug-induced ototoxicity focus on the cochleotoxic effect, while reports on the vestibulotoxic effect are relatively rare [4] [5] [6] [7] [8] [9] [10] . This fact may be due to several reasons. Cochlear damage can be evaluated (by audiometric tests) easier than vestibular damage (clinical examination and measurement of vestibular function make use of instruments not available in all hospitals). Cochlear damage usually is permanent with an irreversible hearing loss, while, in many patients with vestibulotoxicity, imbalance can remain inadvertent. Patients may accept vestibular symptoms as part of their disease and impairment of their general status. Compensatory mechanisms provided by other afferent signals (visual and proprioceptive) can contribute to ameliorate the clinical perception of vestibular symptoms.
It is likely that vestibulotoxicity is underestimated by clinicians. Drug-induced ototoxic damage on the posterior labyrinth frequently causes an important imbalance with an impairment in the quality of life. Thus, it becomes relevant to recognize, evaluate, and quantify an imbalance secondary to vestibulotoxicity. A high index of suspicion is required to avoid that the diagnosis of vestibulotoxicity will be overlooked and to ensure an adequate treatment (such as vestibular rehabilitation) to improve patient equilibrium.
The objective of this study is to report different causes of vestibulotoxicity in patients with instability.
MATERIALS and METHODS
A prospective study in patients diagnosed with chronic imbalance due to drug-induced vestibulotoxicity was performed. Patients who were diagnosed in a Neurotology Unit of a tertiary hospital (Complexo Hospitalario Universitario de Santiago de Compostela, Spain) over 16 years (from 1999 to 2014) were included. The study was approved by the local Independent Ethics Committee, and all patients granted their informed consent to participate in it. All patients underwent the following protocol:
• A complete history (it is necessary to exclude other possible causes of symptoms and signs observed The inclusion criteria were as follows:
• Absence of a history of balance disorders before starting ototoxic drug administration. • Acute onset of dizziness or imbalance during or just after ototoxic drug administration.
• Persistent symptoms for at least three months. Data from patients were entered into a database created for this purpose.
RESULTS
There were 18 patients (11 women and 7 men). The mean age was 60.2 years (standard deviation: 16.41; range: 21-78 years). Six of them showed both cochlear and vestibular damage, while 12 were affected only by posterior labyrinthine damage.
With regard to the drug involved in toxicity, four groups can be identified:
• Antibiotics (nine patients). Eight patients received systemic gentamicin alone (two patients) or associated to vancomycin (five) or to metronidazole (one patient). The remaining patient received amoxicillin/clavulanic acid and azithromycin. Clinical data are shown in Table 1. • Cytostatics (four patients): The drugs administered to and clinical data of these patients are shown in Table 2 .
• Anti-tuberculosis medicinal products (three patients): Ethambutol, plus either pyrazinamide and isoniazid, or rifampicin. • Other drugs: One patient received tamoxifen (for the treatment of breast cancer) and another received melphalan (therapy for amyloidosis).
The clinical data for these last two groups of patients are shown in Table 3 .
The symptom reported by all studied patients was instability, which showed different patterns:
• In six patients, the instability perception was continuous.
• Eleven patients complained of instability when they were on foot and walking. In the remaining patient, instability was discontinuous, being more intense in the morning.
In 13 patients, instability was the only symptom reported. The remaining five patients complained of other concomitant symptoms such as oscillopsia (two), bilateral tinnitus (two), and hearing loss (or exacerbation of a previous hearing loss) (two).
Six patients had normal pure tone audiometry results, while 12 had sensorineural hearing loss:
• A high-frequency hearing loss in 10 patients 
A mild hearing loss in all frequencies in the remaining patient.
All patients had an abnormal SOT on CDP. The SOT average balance score was 52.33 (SD: 14.88). With regard to the posturographic pattern, six patients showed a pure vestibular-deficient type, 10 showed a somatosensory-dependent pattern (with visual and vestibular deficits), and the remaining two had all inputs affected (somatosensory, visual, and vestibular).
None of the patients had spontaneous nystagmus or saccades with the oculocephalic maneuver (Halmagyi test). Caloric tests were bilaterally affected in all patients. Reduced (13 patients) or absent (five) caloric responses were demonstrated.
With regard to treatment, five patients did not receive treatment (four of them experienced a spontaneous improvement in their symptoms and one died as consequence of a previous illness). The remaining 13 patients underwent therapeutic vestibular rehabilitation:
• Seven patients: Walking and performing home vestibular retraining exercises • Six patients: Undergoing instrumental vestibular rehabilitation by dynamic posturography
In the majority of patients, the clinical course was good. Only three patients complained of persistent problems of instability with handicapping effects. In the remaining patients, symptoms markedly improved because of vestibular rehabilitation exercises.
DISCUSSION
The use of ototoxic drugs is relatively common, particularly in patients with severe potentially life-threatening diseases (including malignant tumors and severe infections). In such cases, it is assumed that the risk of not using these drugs is greater than the risk of their potential ototoxic effects. Due to an impaired general clinical status of many of these patients, the disturbances of balance consistent with posterior labyrinthine toxic damage can remain inadvertent or be attributed to other causes. Thus far, most studies on drug-induced ototoxicity are limited to the cochleotoxic effect, while reports on the vestibulotoxic effect are relatively rare.
In many cases, pharmacological treatment includes some drugs, so it becomes difficult to elucidate which of these compounds is the cause of ototoxicity. The mechanisms of action of some of them are known. Aminoglycosides are capable of stimulating the formation of reactive oxygen species that play an important role in inner ear damage. This damage is ameliorated by the presence of free radical scavengers [11] . The presence of nitric oxide synthase was demonstrated in the vestibular epithelium. Nitric oxide may contribute to the induction of apoptosis in vestibular hair cells due to aminoglycosides [12] .
Labyrinthine damage induced by other drugs has also been reported [4] [5] [6] [7] [8] [9] [10] 13] . This is the case for cisplatin, a chemotherapeutic agent that causes vestibular dysfunction. In animal models, cisplatin induces vestibulotoxicity by altering ATPase activities (cisplatin inhibits ATPase activities) and increasing oxidative stress in labyrinths [13] . It is well known that glutathione and glutathione-related enzymes protect against oxidative cell injury caused by free radicals. Specific changes in glutathione levels and enzymes in glutathione metabolism have been found with cisplatin treatment [14] . These findings are in agreement with the proposed mechanism of action based on oxidative stress.
We focused our attention on the fact that the vestibulotoxic potential of cytostatics has scarcely been studied. Their cochleotoxic potential has been reported in some studies, not so the vestibular damage [5, 10, 13, [15] [16] [17] . It is remarkable that vestibulotoxicity and cochleotoxicity do not always simultaneously occur. In our series of 18 patients, only one-third of them experienced symptoms consistent with cochlear affectation. This absence of auditory damage in many patients might also explain that vestibular damage remains undetected as patients and physicians ascribe imbalance to other causes. The finding of a normal auditory function does not imply that vestibular function is also unimpaired [3] . However, we consider important to detect this type of damage. Nowadays, neurotology provides us with a battery of diagnostic methods that allow us to confirm balance disorders (e.g., dynamic posturography) and assess the labyrinthine damage (e.g., Halmagyi test, videonystagmographic record of spontaneous nystagmus, and caloric tests). Once damage occurred, many patients experienced a spontaneous improvement of symptoms, explained by the contribution of other body systems (visual and proprioceptive) to the maintenance of balance. These inputs are usually able to compensate the affected vestibular function. In cases where this compensation is not achieved, therapeutic strategies (such as vestibular rehabilitation) can be applied to stimulate and increase this compensation. Vestibular rehabilitation is particularly useful in elderly people because in these patients, compensation mechanisms are weakened and less effective [18] .
We propose that patients with instability undergo vestibular rehabilitation to reduce the clinical effects of vestibulotoxicity. In addition, it is important to ensure an early diagnosis and prevent this ototoxicity. Suspicion by clinicians is key to recognize the symptoms and signs of posterior labyrinthine damage. In these cases, the immediate discontinuance of vestibulotoxic drug administration and its replacement by other non-vestibulotoxic drugs are the best chance to avoid damage to the inner ear. However, there are patients with severe diseases where the cessation of drug administration is not possible. Different studies have suggested that the co-administration of substances with protective effects against drug-induced vestibulotoxicity in such patients reduces the adverse effects of treatment [19] [20] [21] .
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